KATSIARYNA VASILYEVA: Open Payments
NPI 1659896025 · BERWYN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,880 in 84 payments from 17 companies in 2025. Trend: 2023 $1,206 · 2024 $710 · 2025 $5,880
Speaker / faculty: $4,104Food & beverage: $1,776
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 46 | $4,663 |
| TG Therapeutics, Inc. | 2 | $275 |
| UCB, Inc. | 10 | $250 |
| SK Life Science, Inc. | 5 | $242 |
| PFIZER INC. | 3 | $56 |
| Axsome Therapeutics, Inc. | 3 | $51 |
| Lundbeck LLC | 2 | $47 |
| Otsuka America Pharmaceutical, Inc. | 2 | $45 |
| Teva Pharmaceuticals USA, Inc. | 2 | $40 |
| Neurelis, Inc. | 2 | $40 |
Products named: QULIPTA, BRIUMVI, UBRELVY, Rystiggo, BOTOX, Nayzilam, NURTEC ODT, Symbravo.
Industry payments across PA — which companies pay providers there.
